Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Business Models and Strategy

 

emeis’ share price rises 34% after release of annual results

Pan-European listed French nursing home group emeis may have turned a corner in its long recovery from the scandal that hit the company in 2022. Its share price has climbed 34% since the release of its annual results on February 6, which emphasised improving occupancy and resident satisfaction despite net profit still being negative.
February 20, 2025

What is the right financing strategy for a provider looking to scale? — in conversation with Carin Eijgenberger, Managing Director – Healthcare at ING

Capital is plentiful, but raising it is expensive, which means companies need to be strategic when considering transactions or investments. At HBI 2025, we’re hosting a panel titled “Preparing for Exit, Acquisition, or Growth: The Banker’s Perspective on Current Financing Options.”  HBI caught up with Carin Eijgenberger, Managing Director, Healthcare at ING, one of the speakers at the upcoming conference, to talk about the current financing landscape for businesses looking to exit, get acquired, or grow. With high costs despite abundant capital, we discuss how companies can stay strategic in this environment.
February 20, 2025

How Straumann is shaping the dental landscape across different markets

HBI recently hosted an oral health webinar with speakers Dr. Neil Sikka, Chief Dental Officer at Bupa Insurance, and Sara Dalmasso, Head of Enterprise Solutions at Straumann Group. The session explored the role of AI in dentistry and how to integrate it effectively, the link between oral health and general health, sustainability, and balancing clinical judgement with the use of technology. Post webinar, here HBI speaks to Dalmasso for a deeper dive on certain points (and new ones), to better understand how Straumann Group is shaping up the dental landscape and what its market learnings are.  
February 20, 2025

Synlab sells Spanish division to Eurofins as part of long term divestment strategy

Pan-European diagnostic labs group Synlab is continuing to divest divisions of its business located in less profitable markets to divert resources towards more profitable markets. It is selling its Spanish division to Eurofins, a major listed multinational labs group, and is also attempting to sell its Romanian division.
November 1, 2024

Kry simplifies shareholder structure to facilitate expansion

Swedish digi-physical healthcare company Kry has voted to significantly simplify its shareholder structure by reducing the number of categories of shares it has and converting most of its preference shares into ordinary shares.
October 31, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us